Wound healing and diabetes mellitus

This publication has 41 references indexed in Scilit:

• Recombinant human platelet‐derived growth factor‐BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open‐label clinical evaluation of efficacy
  Wound Repair and Regeneration, 2000
• Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind study
  Diabetes Care, 1998
• Expression of Interleukin-1alpha, Interleukin-6, and Basic Fibroblast Growth Factor by Cultured Skin Substitutes before and after Grafting to Full-Thickness Wounds in Athymic Mice
  The Journal of Trauma: Injury, Infection, and Critical Care, 1996
• Use of Dermagraft, a Cultured Human Dermis, to Treat Diabetic Foot Ulcers
  Diabetes Care, 1996
• Induction of Keratinocyte Growth Factor Expression Is reduced and Delayed During Wound Healing in the Genetically Diabetic Mouse
  Journal of Investigative Dermatology, 1994
• Synergistic actions of platelet‐derived growth factor and the insulin‐like growth factors in vivo
  Wound Repair and Regeneration, 1993
• Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state
  Burns, 1989
• Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue Remodeling
  Science, 1988
• Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
  New England Journal of Medicine, 1988
• Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic Complications
  New England Journal of Medicine, 1987